Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

New drug shows promise for better hair growth in baldness treatment.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Clascoterone safely promotes hair growth similar to minoxidil.

Clascoterone is safe for the heart, even at high doses.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Hair loss in black women needs more research, early intervention, and community education.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for hair loss may target specific pathways and generate new hair follicles.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Use antiandrogens and other treatments for hair loss.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

People with alopecia who are more resilient tend to feel less stressed.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.